Outlook Pharmaceuticals Inc is categorized under Mail Order Pharmaceuticals in Cincinnati, OH and active since 2004.
Outlook Pharmaceuticals Inc was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Kerrin Antonsson, President at the company’s single location by writing to 747 Tusculum Avenue, Cincinnati, Ohio OH 45226 or by phoning (513) 533-3379. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Outlook Pharmaceuticals Inc |
Contact Person: | Kerrin Antonsson, President |
Address: | 747 Tusculum Avenue, Cincinnati, Ohio 45226 |
Phone Number: | (513) 533-3379 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Mail Order Pharmaceuticals |
SIC Code: | 5961 |
NAICS Code: | 4461100 |
Share This Business: |
Outlook Pharmaceuticals Inc was started in 2004 to provide professional Mail Order Pharmaceuticals under the SIC code 5961 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Kerrin Antonsson, President for inquiries that concern Outlook Pharmaceuticals Inc by calling the company number (513) 533-3379, as your correspondence is most welcome. Additionally, the physical location of the single location of Outlook Pharmaceuticals Inc can be found at the coordinates 39.11444,-84.427042 as well as the street address 747 Tusculum Avenue in Cincinnati, Ohio 45226.
For its online presence, you may visit Outlook Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.